News

The TaNeDS program was launched in Japan in 2011 to help discover new lines of research through open innovation. From 2013, it expanded abroad, opening up to researchers

Bile acids are essential for regulating cholesterol metabolism and the intestinal digestion and absorption of fat. Their signaling functions play an important role in chronic disorders, sepsis, or

Boehringer Ingelheim continues to grow the evidence base for Pradaxa to improve care for patients at risk of blood clots and today announces the initiation of Phase III

The active substance in Somatuline is lanreotide acetate, a somatostatin analogue that inhibits the secretion of several endocrine, exocrine and paracrine amines and peptides. Decision from the FDA

The commercialization of the product will be done in Hong Kong and Macao Special Administrative Regions and Taiwan. As part of the deal, Eddingpharm will oversee the clinical

Ryzodeg is a combination of insulin degludec and insulin aspart in the ratio of 70% and 30%, respectively. It is the first combination of a basal insulin with

In the US, Vimpat is already approved as adjunctive treatment for partial-onset seizures in patients belonging to this age group. The new indication means that adults aged 17

The trial evaluated clinical and demographic predictors of all-cause hospitalization in patients with VTE, which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). During the 12-month extended

The trial evaluated 96 New York Heart Association (NYHA) Class II-III patients with heart failure and an ejection fraction of less than 35%. During the trial, all patients